Hawaii 2022 Regular Session

Hawaii Senate Bill SB604

Introduced
1/22/21  

Caption

Related To Prescription Drug Costs.

Impact

If enacted, SB604 would amend the Hawaii Revised Statutes to create a new part dedicated to regulating prescription drug prices. The Insurance Commissioner would be tasked with compiling an annual list of the 250 most costly prescription drugs in the state and establishing a corresponding maximum price for each, aligned with Canadian prices. Additionally, the bill prohibits state entities, health plans, and pharmacies from purchasing these referenced drugs at prices higher than the rates established. This could significantly reduce the financial burden on consumers in Hawaii and is expected to streamline drug access by ensuring health plans adhere to more affordable pricing structures.

Summary

Senate Bill 604 aims to address the high costs of prescription drugs in Hawaii by establishing maximum wholesale drug prices based on the prices in Canada. The bill highlights the significant difference in drug prices between the United States and other countries, noting that Americans spend approximately $1,200 annually on prescription drugs, while Canadians pay about one-third of that amount. The underlying reason for this disparity is the lack of federal regulation on drug prices in the U.S., which leads to fragmented negotiations between health insurers and drug manufacturers that fail to incentivize lower pricing. As a result, the bill seeks to implement mechanisms that will allow Hawaii residents to benefit from lower drug costs.

Contention

Discussion around SB604 is likely to center on the implications of limiting drug prices and the challenges that may arise with pharmaceutical companies. Critics may argue that the bill could discourage drug manufacturers from offering their products in Hawaii, citing concerns about profitability. Furthermore, stakeholders may point out that such regulations may indirectly lead to fewer new drugs being introduced to the market due to reduced incentives for innovation. Supporters, however, emphasize the urgent need to alleviate exorbitant drug costs, framing the bill as a necessary step toward making healthcare more accessible for all residents.

Companion Bills

HI HB18

Same As Related To Prescription Drug Costs.

Similar Bills

HI HB18

Related To Prescription Drug Costs.

RI S0098

Prescription Drug Cost Protection

RI H5431

Prescription Drug Cost Protection

OK SB734

Prescription drugs; prohibiting certain entities from purchasing prescription drugs in excess of certain rate. Effective date.

ND SB2031

A prescription drug reference rate pilot program; to provide for a legislative management report; to provide a penalty; and to provide an expiration date.

CT SB01202

An Act Concerning Prescription Drug Affordability.

RI S2076

Prescription Drug Cost Protection

RI H7877

Prescription Drug Cost Protection